What, Why & How Podcast
SUBSCRIBE: Spotify | Apple Podcasts | iHeartRadio | Podbean
IPA’s What, Why & How podcast unravels the intricacies of pharmacy and healthcare law and regulation, from Congress to the Board of Pharmacy. Each month, IPA’s CEO, Matt Pitlick, welcomes a special guest to explore WHAT changes occurred, WHY action was taken, and HOW these changes will impact pharmacy practice.
2026
Episode #64: July 2026 – Your Voice in Pharmacy Regulation
On this episode of IPA’s What, Why & How podcast, IPA’s Vice President of Professional Affairs, Brian Wall, sits down with Iowa Board of Pharmacy Chair Erik Maki and Vice Chair Connie Connolly to discuss public service, meaningful engagement in the regulatory process, and key takeaways from the Board’s July meeting.
Episode #63: June 2026 – Updates from the Iowa Board of Pharmacy
On this episode of IPA’s What, Why & How podcast, IPA’s Vice President of Professional Affairs, Brian Wall, welcomes Anne Schlepphorst and Craig Ford, PharmD, to share insights from the May 5-6, 2026, Iowa Board of Pharmacy meeting, as well as advice for those interested in association or regulatory leadership roles.
Episode #62: March 2026 – Uniform MPJE: Iowa’s Next Big Licensure Shift
On this episode of IPA’s What, Why & How podcast, IPA’s Vice President of Professional Affairs, Brian Wall, welcomes Jasmina Bjegovic, PharmD, and Andrew Funk, PharmD, from the National Association of Boards of Pharmacy (NABP) to discuss the transition from the Iowa MPJE to the Uniform MPJE. Tune in to learn what stayed the same, what has changed, and how learners can best prepare for this new law exam format.
2025
Episode #64: July 2026 – Your Voice in Pharmacy Regulation
On this episode of IPA’s What, Why & How podcast, IPA’s Vice President of Professional Affairs, Brian Wall, sits down with Iowa Board of Pharmacy Chair Erik Maki and Vice Chair Connie Connolly to discuss public service, meaningful engagement in the regulatory process, and key takeaways from the Board’s July meeting.
Episode #63: June 2026 – Updates from the Iowa Board of Pharmacy
On this episode of IPA’s What, Why & How podcast, IPA’s Vice President of Professional Affairs, Brian Wall, welcomes Anne Schlepphorst and Craig Ford, PharmD, to share insights from the May 5-6, 2026, Iowa Board of Pharmacy meeting, as well as advice for those interested in association or regulatory leadership roles.
Episode #62: March 2026 – Uniform MPJE: Iowa’s Next Big Licensure Shift
On this episode of IPA’s What, Why & How podcast, IPA’s Vice President of Professional Affairs, Brian Wall, welcomes Jasmina Bjegovic, PharmD, and Andrew Funk, PharmD, from the National Association of Boards of Pharmacy (NABP) to discuss the transition from the Iowa MPJE to the Uniform MPJE. Tune in to learn what stayed the same, what has changed, and how learners can best prepare for this new law exam format.
Episode #61: December 2025 – Compounding, MedSpas, and Policies & Procedures
On this episode of IPA’s What, Why & How podcast, IPA CEO Matt Pitlick welcomes Anne Schlepphorst, Executive Director of the Iowa Board of Pharmacy, as well as Jill Kremmin, PharmD, BCPS, a compliance officer for northwest and western Iowa. Anne and Jill provide an update from the latest Board of Pharmacy meeting, specifically related to compounding.
Episode #60: October 2025 – An Update from the Iowa Prescription Monitoring Program (PMP)
On this episode of IPA’s What, Why & How podcast, IPA’s Vice President of Professional Affairs, Brian Wall, welcomes Maggie Phelps, PharmD, Program Administrator at the Iowa Prescription Monitoring Program (PMP), to discuss her work with the Board, recent enhancements to the PMP, as well as tips, tricks and resources for pharmacies using the PMP.
Episode #59: September 2025 – Standard of Care, Immunizations & Updates from the Board
On this episode of IPA’s What, Why & How podcast, IPA CEO Matt Pitlick welcomes Anne Schlepphorst, Bureau Chief of Monitoring and Executive Director of the Iowa Board of Pharmacy, for an update from the Board, covering standard of care, immunizations, and more.
Episode #58: July 2025 – Legislative Session Recap: The Road to PBM Reform
On this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes IPA lobbyist Kate Walton to recap the 2025 Iowa Legislative Session and the steps that led to the passage of IPA’s PBM reform bill, SF 383, which was signed into law by Governor Kim Reynolds on June 11, 2025.
Episode #57: April 2025 – NABP: The UPJE and Future of License Portability
On this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes Andrew Funk, PharmD, Director of Member Relations and Government Affairs at NABP. Kate and Andrew discuss what the Uniform Multistate Pharmacy Jurisprudence Exam (UPJE) looks like, why NABP deemed it valuable, and how it will impact pharmacy practice.
Episode #56: March 2025 – PBM Whack-A-Mole
On this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes Scott Pace, PharmD, JD, a pharmacy owner and partner at Impact Management Group (IMG), a government relations, public affairs, and consulting firm based in Little Rock, Arkansas. Kate and Scott discuss PBM reform, the role of the courts, PSAOs and more.
Episode #55: February 2025 – Pharmacists in Elected Office
On this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes Iowa pharmacist and State Representative Brett Barker, PharmD, to discuss his public service leading up to the Iowa Legislature, why it’s important for pharmacists to serve in elected office, and how pharmacy professionals can get involved at the local, state or national level.
Episode #54: January 2025 – IPA Legislative Briefing
On this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes IPA lobbyists Matt Eide and Kate Walton to discuss pharmacy’s top priorities, tips for engaging with your legislators, and more. Pharmacy Day on the Hill attendees are encouraged to listen to this episode before February 5, 2025.
On this episode of IPA’s What, Why & How podcast, IPA CEO Matt Pitlick welcomes Anne Schlepphorst, Executive Director of the Iowa Board of Pharmacy, as well as Jill Kremmin, PharmD, BCPS, a compliance officer for northwest and western Iowa. Anne and Jill provide an update from the latest Board of Pharmacy meeting, specifically related to compounding.
Episode #60: October 2025 – An Update from the Iowa Prescription Monitoring Program (PMP)
On this episode of IPA’s What, Why & How podcast, IPA’s Vice President of Professional Affairs, Brian Wall, welcomes Maggie Phelps, PharmD, Program Administrator at the Iowa Prescription Monitoring Program (PMP), to discuss her work with the Board, recent enhancements to the PMP, as well as tips, tricks and resources for pharmacies using the PMP.
Episode #59: September 2025 – Standard of Care, Immunizations & Updates from the Board
On this episode of IPA’s What, Why & How podcast, IPA CEO Matt Pitlick welcomes Anne Schlepphorst, Bureau Chief of Monitoring and Executive Director of the Iowa Board of Pharmacy, for an update from the Board, covering standard of care, immunizations, and more.
Episode #58: July 2025 – Legislative Session Recap: The Road to PBM Reform
On this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes IPA lobbyist Kate Walton to recap the 2025 Iowa Legislative Session and the steps that led to the passage of IPA’s PBM reform bill, SF 383, which was signed into law by Governor Kim Reynolds on June 11, 2025.
Episode #57: April 2025 – NABP: The UPJE and Future of License Portability
On this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes Andrew Funk, PharmD, Director of Member Relations and Government Affairs at NABP. Kate and Andrew discuss what the Uniform Multistate Pharmacy Jurisprudence Exam (UPJE) looks like, why NABP deemed it valuable, and how it will impact pharmacy practice.
Episode #56: March 2025 – PBM Whack-A-Mole
On this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes Scott Pace, PharmD, JD, a pharmacy owner and partner at Impact Management Group (IMG), a government relations, public affairs, and consulting firm based in Little Rock, Arkansas. Kate and Scott discuss PBM reform, the role of the courts, PSAOs and more.
Episode #55: February 2025 – Pharmacists in Elected Office
On this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes Iowa pharmacist and State Representative Brett Barker, PharmD, to discuss his public service leading up to the Iowa Legislature, why it’s important for pharmacists to serve in elected office, and how pharmacy professionals can get involved at the local, state or national level.
Episode #54: January 2025 – IPA Legislative Briefing
On this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes IPA lobbyists Matt Eide and Kate Walton to discuss pharmacy’s top priorities, tips for engaging with your legislators, and more. Pharmacy Day on the Hill attendees are encouraged to listen to this episode before February 5, 2025.
Episode #53: December 2024 – Federal Advocacy: 2024 RecapOn this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes Kyle Robb, PharmD, BCPS, Director of State Policy & Advocacy at ASHP, and Anna Legreid Dopp, PharmD, CPHQ, Senior Director of Government Relations at ASHP, to discuss ASHP’s top priorities and what’s happening at the federal level.
Episode #52: November 2024 – Standard of Care in Pharmacy Practice: Idaho + AlaskaOn this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes pharmacy colleagues from Idaho and Alaska to share what standard of care means in their respective states and how this regulatory framework allows pharmacists to better care for their patients.
Episode #51: October 2024 – Provider Status: Iowa MedicaidOn this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes Abby Cate, PharmD, Pharmacy Director at Iowa Medicaid, to discuss pharmacy provider status and pharmacist enrollment.
Episode #52: November 2024 – Standard of Care in Pharmacy Practice: Idaho + AlaskaOn this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes pharmacy colleagues from Idaho and Alaska to share what standard of care means in their respective states and how this regulatory framework allows pharmacists to better care for their patients.
Episode #51: October 2024 – Provider Status: Iowa MedicaidOn this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes Abby Cate, PharmD, Pharmacy Director at Iowa Medicaid, to discuss pharmacy provider status and pharmacist enrollment.
Episode #50: August 2024 – Iowa Board of Pharmacy: New Executive Director & New RulesOn this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes Anne Schlepphorst, Executive Director of the Iowa Board of Pharmacy, to discuss her many roles within the Department of Inspections, Appeals, & Licensing (DIAL), as well as the timeline for the new Board of Pharmacy rules pursuant to Governor Reynolds’ Executive Order #10 and HF 555.
Episode #49: May 2024 – 2024 Legislative Session RecapOn this episode of IPA’s What, Why & How podcast, Seth Brown welcomes Representative John Forbes, RPh, District 44, to discuss the outcome of the 2024 Legislative Session and IPA’s continued efforts toward our legislative priorities.
Episode #48: February 2024 – Oversight of PBMs: An Update from the Iowa Insurance DivisionOn this episode of IPA’s What, Why & How podcast, Seth Brown welcomes Andria Seip, J.D., M.S., Senior Health Policy Specialist with the Iowa Insurance Division (IID), to discuss data collected through complaints by Iowa pharmacists and IID’s focus going forward.
Episode #47: January 2024 – IPA Legislative BriefingOn this episode of IPA’s What, Why & How podcast, Seth Brown welcomes IPA lobbyist Kate Walton of Eide-Walton Lobbying and Government Relations. Kate describes the current makeup of the Iowa Legislature as we head into the 2024 Legislative Session.
2023
Episode #46: November 2023 – DIR Cliff: What It Is & What’s Ahead in 2024
For the final episode of 2023, IPA’s Seth Brown welcomes Michael Baxter, Vice President of Federal Government Affairs at the American Pharmacists Association (APhA), to discuss direct and indirect remuneration (DIR) fees and the Medicare Part D Final Rule going into effect January 1, 2024.
Episode #45: August 2023 – State Government Realignment & Board of Pharmacy Impact
Following the August 29 Iowa Board of Pharmacy meeting, IPA’s Seth Brown welcomes Sue Mears from the Board of Pharmacy to discuss Iowa's state government realignment and what it means for the Board of Pharmacy.
Episode #44: May 2023 – Executive Agency Rulemaking and Executive Order #10
Following the May 2 Iowa Board of Pharmacy meeting, IPA’s Seth Brown welcomes Sue Mears from the Board of Pharmacy to discuss Executive Agency rulemaking and Executive Order #10.
Episode #43: February 2023 – Iowa Pharmacy Disposal Kit Dispensing Program
Following the February 28 Iowa Board of Pharmacy meeting, IPA staff welcomes special guest Mitch Barnett, Associate Director of the Prescription Monitoring Program (PMP) at the Board of Pharmacy, to discuss the Board’s Disposal Kit Dispensing Program.
Episode #42: January 2023 – IPA Legislative Priorities & Iowa PMP
Following the January 10 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss IPA’s 2023 Legislative Priorities, the Board’s rulemaking related to the Iowa Prescription Monitoring Program (PMP), and more.
For the final episode of 2023, IPA’s Seth Brown welcomes Michael Baxter, Vice President of Federal Government Affairs at the American Pharmacists Association (APhA), to discuss direct and indirect remuneration (DIR) fees and the Medicare Part D Final Rule going into effect January 1, 2024.
Episode #45: August 2023 – State Government Realignment & Board of Pharmacy Impact
Following the August 29 Iowa Board of Pharmacy meeting, IPA’s Seth Brown welcomes Sue Mears from the Board of Pharmacy to discuss Iowa's state government realignment and what it means for the Board of Pharmacy.
Episode #44: May 2023 – Executive Agency Rulemaking and Executive Order #10
Following the May 2 Iowa Board of Pharmacy meeting, IPA’s Seth Brown welcomes Sue Mears from the Board of Pharmacy to discuss Executive Agency rulemaking and Executive Order #10.
Episode #43: February 2023 – Iowa Pharmacy Disposal Kit Dispensing Program
Following the February 28 Iowa Board of Pharmacy meeting, IPA staff welcomes special guest Mitch Barnett, Associate Director of the Prescription Monitoring Program (PMP) at the Board of Pharmacy, to discuss the Board’s Disposal Kit Dispensing Program.
Episode #42: January 2023 – IPA Legislative Priorities & Iowa PMP
Following the January 10 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss IPA’s 2023 Legislative Priorities, the Board’s rulemaking related to the Iowa Prescription Monitoring Program (PMP), and more.
2022
Special Edition: December 2022 – Iowa Insurance Division PBM Rules
On December 5, IPA’s Director of Public Affairs, Seth Brown, and Senior Policy Advisor, Brett Barker, recorded a special podcast episode on the Iowa Insurance Division’s release of the PBM rules following the passage of the PBM bill last session.
Episode #41: October 2022 – USP Compounding Standards & Delegation of Technical Functions
Following the October 25 Iowa Board of Pharmacy meeting, IPA staff and Andrew Funk from the Board of Pharmacy discuss the role of the Board and programs offered, updated USP compounding standards, and delegation of technical functions to nurses.
Episode #40: August 2022 – Rulemaking Process, Compounding & IMP3 Program
Following the August 24 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the rulemaking process and how a rule is adopted, as well as the Board’s newly adopted compounding rule. In addition, Becky Carlson speaks on the IMP3 Program and its importance in Iowa.
Episode #39: June 2022 – Updated Security Rules & Statewide Protocol Changes
Following the June 28 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the Board’s updated security and controlled substance accountability rules, as well as changes to the Statewide Protocols for naloxone, immunization and tobacco cessation.
Episode #38: May 2022 – Compounding Pharmacies, Comment Periods & Security Changes
Following the May 3 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the FDA’s memorandum of understanding (MOU) for compounding pharmacies distributing medications interstate, the REMS comment period for opioid analgesics, new BOP security rules and more.
Episode #37: March 2022 – Controlled Substances, Practicing Nurses & Telepharmacy
Following the March 1 Iowa Board of Pharmacy meeting, IPA’s Vice President of Government Affairs, Brett Barker, and Sue Mears from the Board of Pharmacy discuss the Board’s 2022 legislation regarding controlled substances and the authority of nurses practicing under a pharmacist’s order, as well as recent rulemaking and telepharmacy provisions from the Board.
Episode #36: January 2022 – USP Revisions, Telepharmacy Rulemaking & Legislative Session
Following the January 11 Iowa Board of Pharmacy meeting, IPA’s Government Relations team and Sue Mears from the Board of Pharmacy discuss federal comment periods for USP revisions, the DEA rulemaking regarding telepharmacy and transfer of electronic prescriptions for controlled substances, as well as recent rulemaking from the Board.
Special Edition: December 2022 – Iowa Insurance Division PBM Rules
On December 5, IPA’s Director of Public Affairs, Seth Brown, and Senior Policy Advisor, Brett Barker, recorded a special podcast episode on the Iowa Insurance Division’s release of the PBM rules following the passage of the PBM bill last session.
Episode #41: October 2022 – USP Compounding Standards & Delegation of Technical Functions
Following the October 25 Iowa Board of Pharmacy meeting, IPA staff and Andrew Funk from the Board of Pharmacy discuss the role of the Board and programs offered, updated USP compounding standards, and delegation of technical functions to nurses.
Episode #40: August 2022 – Rulemaking Process, Compounding & IMP3 Program
Following the August 24 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the rulemaking process and how a rule is adopted, as well as the Board’s newly adopted compounding rule. In addition, Becky Carlson speaks on the IMP3 Program and its importance in Iowa.
Episode #39: June 2022 – Updated Security Rules & Statewide Protocol Changes
Following the June 28 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the Board’s updated security and controlled substance accountability rules, as well as changes to the Statewide Protocols for naloxone, immunization and tobacco cessation.
Episode #38: May 2022 – Compounding Pharmacies, Comment Periods & Security Changes
Following the May 3 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the FDA’s memorandum of understanding (MOU) for compounding pharmacies distributing medications interstate, the REMS comment period for opioid analgesics, new BOP security rules and more.
Episode #37: March 2022 – Controlled Substances, Practicing Nurses & Telepharmacy
Following the March 1 Iowa Board of Pharmacy meeting, IPA’s Vice President of Government Affairs, Brett Barker, and Sue Mears from the Board of Pharmacy discuss the Board’s 2022 legislation regarding controlled substances and the authority of nurses practicing under a pharmacist’s order, as well as recent rulemaking and telepharmacy provisions from the Board.
Episode #36: January 2022 – USP Revisions, Telepharmacy Rulemaking & Legislative Session
Following the January 11 Iowa Board of Pharmacy meeting, IPA’s Government Relations team and Sue Mears from the Board of Pharmacy discuss federal comment periods for USP revisions, the DEA rulemaking regarding telepharmacy and transfer of electronic prescriptions for controlled substances, as well as recent rulemaking from the Board.
2021
Episode #35: November 2021 – Telepharmacy, Technicians & Upcoming Legislation
Following the November 10 Iowa Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss rule changes impacting telepharmacy, technicians, and potential legislation in the 2022 session.
Episode #34: August 2021 – Collaborative Practice Rules and Test & Treat Protocols
Following the August 31 Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss the recently noticed collaborative practice rules and board-approved test and treat protocols.
Episode #33: July 2021 – Pharmacy Technician Administered Vaccines, Statewide Protocols, and Collaborative Practice
Following the July 14 Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss emergency rules impacting pharmacy technician-administered vaccines, updated statewide protocols, and next steps for new collaborative practice rules.
Episode #32: May 2021 – Legislation Implementation and Statewide Protocol Updates
Following the May 12 Board of Pharmacy Meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss important upcoming dates for pharmacists to know, implementation of legislation, and updates to Iowa’s statewide protocols.
Episode #31: March 2021 – Rule Changes for Technicians, Support Persons, and PMP
Following the March 11 Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss changes to the rules governing technicians, pharmacy support persons, and the PMP.
Episode #30: January 2021 – Legislative Proposals and COVID-19 Vaccine Distribution
Following the January 12 Board of Pharmacy meeting, IPA's Vice President of Professional Affairs, Anthony Pudlo, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss IPA and BOP’s legislative proposals and updates regarding the COVID-19 vaccine distribution in Iowa.
Following the November 10 Iowa Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss rule changes impacting telepharmacy, technicians, and potential legislation in the 2022 session.
Episode #34: August 2021 – Collaborative Practice Rules and Test & Treat Protocols
Following the August 31 Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss the recently noticed collaborative practice rules and board-approved test and treat protocols.
Episode #33: July 2021 – Pharmacy Technician Administered Vaccines, Statewide Protocols, and Collaborative Practice
Following the July 14 Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss emergency rules impacting pharmacy technician-administered vaccines, updated statewide protocols, and next steps for new collaborative practice rules.
Episode #32: May 2021 – Legislation Implementation and Statewide Protocol Updates
Following the May 12 Board of Pharmacy Meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss important upcoming dates for pharmacists to know, implementation of legislation, and updates to Iowa’s statewide protocols.
Episode #31: March 2021 – Rule Changes for Technicians, Support Persons, and PMP
Following the March 11 Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss changes to the rules governing technicians, pharmacy support persons, and the PMP.
Episode #30: January 2021 – Legislative Proposals and COVID-19 Vaccine Distribution
Following the January 12 Board of Pharmacy meeting, IPA's Vice President of Professional Affairs, Anthony Pudlo, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss IPA and BOP’s legislative proposals and updates regarding the COVID-19 vaccine distribution in Iowa.
2020
Episode #29: December 2020 – Electronic Prescribing and Pharmacists’ Continued Role in the COVID-19 Pandemic
Following the impromptu December 12 Board of Pharmacy meeting, IPA's Vice President of Professional Affairs, Anthony Pudlo, and Sue Mears from the Board of Pharmacy discuss wrapping up final waiver requests for electronic prescribing, the Iowa Dental Board seeking authorization for dentists to immunize, and pharmacist administration of COVID-19 testing and vaccination.
Episode #28: November 2020 – Compounding, Controlled Substances, and Legislative Agenda
Following the November 17 Board of Pharmacy meeting, IPA's Director of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss board action on the FDA’s memorandum of understanding regarding compounding, proposed rules impacting controlled substances and the PMP, and the Board’s legislative agenda.
Episode #27: August 2020 – Pediatric Vaccinations, Licensing Updates, and Cannabidiol Products
Following the August 26 Board of Pharmacy meeting, IPA's Director of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss the recent declaration allowing pharmacists to perform pediatric vaccinations, updates to pharmacist licensing following recent legislation, and the scheduling and sale of products containing cannabidiol.
Episode #26: June 2020 – Recent Legislation and New Rules Related to Controlled Substances and Pharmacy Interns
Following the June 23 Board of Pharmacy meeting, IPA's Director of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss recently passed legislation impacting the Board and pharmacy, as well as new rules promulgated by the Board related to controlled substances and pharmacy interns.
Episode #25: May 2020 – Board of Pharmacy’s Response to COVID-19
Following the May 5 Board of Pharmacy meeting, IPA's Director of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss the Board's response to COVID-19, including granting emergency licenses to recent graduates.
Episode #24: February 2020 – Iowa Board of Pharmacy Meeting
Following the February 26 Iowa Board of Pharmacy meeting, Episode 24 features discussion with Casey Ficek from IPA and Sue Mears from the Board of Pharmacy on proposed rule changes on comprehensive medication lists by pharmacy technicians, new PMP resources, and updates to current statewide protocols.
Episode #23: January 2020 – Iowa Board of Pharmacy Meeting
Episode #23: January 2020 – Iowa Board of Pharmacy Meeting
IPA’s Casey Ficek and Sue Mears from the Board of Pharmacy recap the January 7-8 Iowa Board of Pharmacy meeting and discuss proposed legislation, FAQs on the e-prescribing mandate, and new rules regarding expedited partner therapy.
.jpg)